{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:23:49Z","timestamp":1772137429524,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"am","delay-in-days":271,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["R38OT1058"],"award-info":[{"award-number":["R38OT1058"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes, Digestive, and Kidney Disease","doi-asserted-by":"crossref","award":["R01DK083961"],"award-info":[{"award-number":["R01DK083961"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 RR024153"],"award-info":[{"award-number":["UL1 RR024153"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR000005"],"award-info":[{"award-number":["UL1TR000005"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jcrc.2018.08.013","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T23:23:27Z","timestamp":1534548207000},"page":"42-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Donor biomarkers as predictors of organ use and recipient survival after neurologically deceased donor organ transplantation"],"prefix":"10.1016","volume":"48","author":[{"given":"Shengnan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghavan","family":"Murugan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3441-3917","authenticated-orcid":false,"given":"Ali","family":"Al-Khafaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Lebovitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Souter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan R.N.","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1995-2653","authenticated-orcid":false,"given":"John A.","family":"Kellum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcrc.2018.08.013_bb0005","unstructured":"http:\/\/www.americantransplantfoundation.org\/about-transplant\/facts-and-myths\/, n.d, 2017."},{"key":"10.1016\/j.jcrc.2018.08.013_bb0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/ajt.12585","article-title":"2012 Annual Data Report: deceased organ donation","volume":"1","author":"Israni","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0015","doi-asserted-by":"crossref","first-page":"I27","DOI":"10.1161\/CIRCULATIONAHA.105.000737","article-title":"Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation","volume":"114","author":"Lima","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0020","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11910-016-0682-1","article-title":"ICU management of the potential organ donor: state of the art","volume":"16","author":"Maciel","year":"2016","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12967-015-0574-1","article-title":"Circulating resistin levels are early and significantly increased in deceased brain dead organ donors, correlate with inflammatory cytokine response and remain unaffected by steroid treatment","volume":"13","author":"Pullerits","year":"2015","journal-title":"J Transl Med"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0030","first-page":"521369","article-title":"Inflammatory signalling associated with brain dead organ donation: from brain injury to brain stem death and posttransplant ischaemia reperfusion injury","volume":"2013","author":"Watts","year":"2013","journal-title":"J Transplant"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0035","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.tp.0000281384.24333.0b","article-title":"Graft produced interleukin-6 functions as a danger signal and promotes rejection after transplantation","volume":"84","author":"Liang","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0040","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.4049\/jimmunol.0803842","article-title":"TLR signals promote IL-6\/IL-17-dependent transplant rejection","volume":"182","author":"Chen","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0045","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2217\/imt.10.33","article-title":"TGF-beta, IL-6, IL-17 and CTGF direct multiple pathologies of chronic cardiac allograft rejection","volume":"2","author":"Booth","year":"2010","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0050","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/j.1600-6143.2009.02706.x","article-title":"Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection","volume":"9","author":"Diaz","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0055","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1093\/ndt\/gfr163","article-title":"Inflammation-associated graft loss in renal transplant recipients","volume":"26","author":"Dahle","year":"2011","journal-title":"Nephrol Dial Transplant Proc"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0060","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1111\/ajt.14228","article-title":"Assessment of Tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients","volume":"17","author":"Choi","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0065","first-page":"89","article-title":"Associated clinical and laboratory markers of donor on allograft function after heart transplant","volume":"31","author":"Braulio","year":"2016","journal-title":"Braz J Cardiovasc Surg"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0070","first-page":"10","article-title":"Factors determining changes in concentrations of pro-inflammatory markers in blood serum in the initial period after kidney transplantation from dead donor","volume":"14","author":"Caban","year":"2009","journal-title":"Ann Transplant"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0075","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1097\/CCM.0b013e318174d89f","article-title":"Increased plasma interleukin-6 in donors is associated with lower recipient hospital-free survival after cadaveric organ transplantation","volume":"36","author":"Murugan","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cytogfr.2015.12.001","article-title":"Secretory leukocyte protease inhibitor (SLPI), a multifunctional protein in the host defense response","author":"Majchrzak-Gorecka","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0085","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s00534-009-0125-3","article-title":"Endogenous protease inhibitor uptake within the graft during reperfusion in human liver transplantation","volume":"17","author":"Ilmakunnas","year":"2010","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0090","first-page":"9","article-title":"Association of increased plasma interleukin-6 and TNF-\u03b1 level in donors with the complication rates in liver transplant recipients","volume":"4","author":"Azarpira","year":"2013","journal-title":"Int J Organ Transplant Med"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.trim.2016.01.006","article-title":"Soluble tumor necrosis factor receptors as predictors of 1-year mortality and renal dysfunction after liver transplantation","volume":"35","author":"Morais","year":"2016","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1540-8191.2006.00189.x","article-title":"Effect of donor age on long-term survival following cardiac transplantation","volume":"21","author":"Topkara","year":"2006","journal-title":"J Card Surg"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0105","doi-asserted-by":"crossref","first-page":"E437","DOI":"10.1111\/j.1399-0012.2011.01461.x","article-title":"Hypertension in standard criteria deceased donors is associated with inferior outcomes following kidney transplantation","volume":"25","author":"Singh","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0110","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s00134-014-3621-0","article-title":"Protocolized fluid therapy in brain-dead donors: the multicenter randomized MOnIToR trial","volume":"41","author":"Al-Khafaji","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0115","first-page":"234","article-title":"Monitoring organ donors to improve transplantation results (MOnIToR) trial methodology","volume":"15","author":"Al-Khafaji","year":"2013","journal-title":"Crit Care Resusc"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v047.i04","article-title":"frailtypack: An R package for the analysis of correlated survival data with frailty models using penalized likelihood estimation or parametrical estimation","volume":"47","author":"Rondeau","year":"2012","journal-title":"J Stat Softw"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0130","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jamasurg.2014.967","article-title":"The impact of meeting donor management goals on the number of organs transplanted per expanded criteria donor: a prospective study from the UNOS Region 5 Donor Management Goals Workgroup","volume":"149","author":"Patel","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0135","doi-asserted-by":"crossref","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0140","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cytogfr.2015.07.004","article-title":"Interleukin-6: Biology, signaling and strategies of blockade","volume":"26","author":"Schaper","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0145","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.it.2012.07.003","article-title":"Interleukin-6: from an inflammatory marker to a target for inflammatory diseases","volume":"33","author":"Rincon","year":"2012","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0150","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/S0735-1097(02)01791-6","article-title":"The interleukin-6\/interleukin-6-receptor system is activated in donor hearts","volume":"39","author":"Plenz","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0155","first-page":"III352","article-title":"Elevated tumor necrosis factor-alpha and interleukin-6 in myocardium and serum of malfunctioning donor hearts","volume":"102","author":"Birks","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0160","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.healun.2009.09.007","article-title":"Activation of JAK-STAT and nitric oxide signaling as a mechanism for donor heart dysfunction","volume":"29","author":"Bulcao","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0165","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1111\/ajt.12492","article-title":"Impact of cytokine expression in the pre-implanted donor lung on the development of chronic lung allograft dysfunction subtypes","volume":"13","author":"Saito","year":"2013","journal-title":"Am J Transplant Proc"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0170","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.transproceed.2007.07.056","article-title":"Determination of interleukin-6 in lung transplantation: association with primary graft dysfunction","volume":"39","author":"Moreno","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0175","doi-asserted-by":"crossref","first-page":"h3557","DOI":"10.1136\/bmj.h3557","article-title":"Long term outcomes of transplantation using kidneys from expanded criteria donors: prospective, population based cohort study","volume":"351","author":"Aubert","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0180","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.jtcvs.2005.12.037","article-title":"Extended donor criteria in lung transplantation: impact on organ allocation","volume":"131","author":"Botha","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0185","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/SLA.0000000000001337","article-title":"Live donor liver transplantation with older (\u226550 years) versus younger (<50 years) donors: does age matter?","volume":"263","author":"Goldaracena","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0190","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jamcollsurg.2008.08.009","article-title":"Advanced donor age alone does not affect patient or graft survival after liver transplantation","volume":"207","author":"Anderson","year":"2008","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0195","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/01.TP.0000095896.07048.BB","article-title":"Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C","volume":"77","author":"Machicao","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0200","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/icvts\/ivw172","article-title":"Impact of donor age on cardiac transplantation outcomes and on cardiac function","volume":"23","author":"Chamogeorgakis","year":"2016","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0205","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/j.healun.2014.01.432","article-title":"Elderly heart transplant recipient long-term survival is not dependent on donor age: a conditional survival analysis","volume":"33","author":"Ravi","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0210","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.athoracsur.2004.02.016","article-title":"Effect of older donor age on risk for mortality after heart transplantation","volume":"78","author":"Gupta","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0215","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/01.tp.0000255583.34329.dd","article-title":"Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes","volume":"83","author":"\u00d8ien","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0220","first-page":"488","article-title":"Age before beauty: the use of \"older\" donor hearts for cardiac transplantation","volume":"18","author":"Young","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0225","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1084\/jem.20050768","article-title":"Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding","volume":"202","author":"Taggart","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0230","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1600-0897.2012.01149.x","article-title":"Secretory leukocyte protease inhibitor binds to Neisseria gonorrhoeae outer membrane opacity protein and is bactericidal","volume":"68","author":"Cooper","year":"2012","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0235","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1470-2045(06)70579-4","article-title":"Proteins with whey-acidic-protein motifs and cancer","volume":"7","author":"Bouchard","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0240","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/hep.26933","article-title":"Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure","volume":"59","author":"Antoniades","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0245","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1600-6143.2008.02158.x","article-title":"The effect of secretory leukocyte protease inhibitor (SLPI) on ischemia\/reperfusion injury in cardiac transplantation","volume":"8","author":"Schneeberger","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0250","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.transproceed.2016.01.048","article-title":"Organ donation from elderly deceased donors and transplantation to elderly recipients in Poland: numbers and outcomes","volume":"48","author":"Lewandowska","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jcrc.2018.08.013_bb0255","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1158\/1055-9965.EPI-09-1220","article-title":"Increased risk for lymphoid and myeloid neoplasms in elderly solid-organ transplant recipients","volume":"19","author":"Quinlan","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944118304921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944118304921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:38:39Z","timestamp":1760125119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944118304921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":51,"alternative-id":["S0883944118304921"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2018.08.013","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Donor biomarkers as predictors of organ use and recipient survival after neurologically deceased donor organ transplantation","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2018.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}